{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05753306",
            "orgStudyIdInfo": {
                "id": "22-004680"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2023-00431",
                    "type": "REGISTRY",
                    "domain": "CTRP (Clinical Trial Reporting Program)"
                },
                {
                    "id": "22-004680",
                    "type": "OTHER",
                    "domain": "Mayo Clinic in Rochester"
                }
            ],
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study",
            "officialTitle": "A Phase II Study of Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients With Gastric Cancer and Limited Peritoneal Metastasis: ROBO-CHIP Trial",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "robotic-cytoreduction-and-hyperthermic-intraperitoneal-chemotherapy-for-treatment-of-gastric-cancer-with-limited-peritoneal-metastasis-robo-chip-study"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-09",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-03-16",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-02-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-02-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-02-22",
            "studyFirstSubmitQcDate": "2023-03-02",
            "studyFirstPostDateStruct": {
                "date": "2023-03-03",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-09-18",
            "lastUpdatePostDateStruct": {
                "date": "2023-09-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This phase II clinical trial tests how well robotic cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in treating patients with gastric cancer that has spread to the tissue that lines the wall of the abdominal cavity (peritoneum). Gastric cancer is the third leading cause of cancer related deaths worldwide and peritoneal metastasis are found in 30% of patients at time of diagnosis. Patients with peritoneal metastasis have poor survival rates. Traditional surgery is done with a large incision and has a high complication rate and longer hospital stays. Robot assisted (robotic) cytoreduction is a surgical option that uses small incisions and there is less risk of complications. HIPEC involves infusing heated chemotherapy into the abdominal cavity during surgery. Robotic cytoreduction together with HIPEC may improve recovery and decrease complications after surgery.",
            "detailedDescription": "PRIMARY OBJECTIVE:\n\nI. To assess short-term morbidity and disease-free survival outcomes for patients with gastric adenocarcinoma with limited low volume peritoneal metastasis and/or positive peritoneal cytology undergoing robotic cytoreduction and hyperthermic intraperitoneal chemotherapy.\n\nSECONDARY OBJECTIVES:\n\nI. To obtain a biorepository for additional translational research including:\n\nIa. Stool samples for shotgun metagenomic sequencing and metabolomic quantification of the fecal microbiome before and after gastrectomy; Ib. Blood and peritoneal tissue biobanked for future investigations; Ic. Patient reported outcomes using the Mayo Clinic Upper Digestive Disease Survey questionnaires at 1, 3, 6 and 12 months.\n\nOUTLINE:\n\nPatients undergo collection of stool and blood sample before and after surgery. Patients also undergo robotic gastrectomy and HIPEC with docetaxel and cisplatin on study. Patients undergo computed tomography (CT), magnetic resonance imaging (MRI), or positron emission tomography (PET)/CT scans throughout the trial."
        },
        "conditionsModule": {
            "conditions": [
                "Gastric Adenocarcinoma",
                "Gastroesophageal Junction Adenocarcinoma",
                "Metastatic Malignant Neoplasm in the Peritoneum"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Treatment (gastrectomy, HIPEC)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients undergo collection of stool and blood sample before and after surgery. Patients also undergo robotic gastrectomy and HIPEC with docetaxel and cisplatin on study. Patients undergo CT, MRI, or PET/CT scans throughout the trial.",
                    "interventionNames": [
                        "Procedure: Biospecimen Collection",
                        "Drug: Cisplatin",
                        "Procedure: Computed Tomography",
                        "Drug: Docetaxel",
                        "Procedure: Gastrectomy",
                        "Drug: Hyperthermic Intraperitoneal Chemotherapy",
                        "Procedure: Magnetic Resonance Imaging",
                        "Procedure: Positron Emission Tomography",
                        "Other: Questionnaire Administration"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "PROCEDURE",
                    "name": "Biospecimen Collection",
                    "description": "Undergo stool and blood sample collection",
                    "armGroupLabels": [
                        "Treatment (gastrectomy, HIPEC)"
                    ],
                    "otherNames": [
                        "Biological Sample Collection",
                        "Biospecimen Collected",
                        "Specimen Collection"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Cisplatin",
                    "description": "Given via HIPEC",
                    "armGroupLabels": [
                        "Treatment (gastrectomy, HIPEC)"
                    ],
                    "otherNames": [
                        "Abiplatin",
                        "Blastolem",
                        "Briplatin",
                        "CDDP",
                        "Cis-diammine-dichloroplatinum",
                        "Cis-diamminedichloridoplatinum",
                        "Cis-diamminedichloro Platinum (II)",
                        "Cis-diamminedichloroplatinum",
                        "Cis-dichloroammine Platinum (II)",
                        "Cis-platinous Diamine Dichloride",
                        "Cis-platinum",
                        "Cis-platinum II",
                        "Cis-platinum II Diamine Dichloride",
                        "Cismaplat",
                        "Cisplatina",
                        "Cisplatinum",
                        "Cisplatyl",
                        "Citoplatino",
                        "Citosin",
                        "Cysplatyna",
                        "DDP",
                        "Lederplatin",
                        "Metaplatin",
                        "Neoplatin",
                        "Peyrone's Chloride",
                        "Peyrone's Salt",
                        "Placis",
                        "Plastistil",
                        "Platamine",
                        "Platiblastin",
                        "Platiblastin-S",
                        "Platinex",
                        "Platinol",
                        "Platinol- AQ",
                        "Platinol-AQ",
                        "Platinol-AQ VHA Plus",
                        "Platinoxan",
                        "Platinum",
                        "Platinum Diamminodichloride",
                        "Platiran",
                        "Platistin",
                        "Platosin"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Computed Tomography",
                    "description": "Undergo CT scan or PET/CT",
                    "armGroupLabels": [
                        "Treatment (gastrectomy, HIPEC)"
                    ],
                    "otherNames": [
                        "CAT",
                        "CAT Scan",
                        "Computed Axial Tomography",
                        "Computerized Axial Tomography",
                        "Computerized Tomography",
                        "CT",
                        "CT Scan",
                        "tomography"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Docetaxel",
                    "description": "Given via HIPEC",
                    "armGroupLabels": [
                        "Treatment (gastrectomy, HIPEC)"
                    ],
                    "otherNames": [
                        "Docecad",
                        "RP56976",
                        "Taxotere",
                        "Taxotere Injection Concentrate"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Gastrectomy",
                    "description": "Undergo robotic gastrectomy",
                    "armGroupLabels": [
                        "Treatment (gastrectomy, HIPEC)"
                    ],
                    "otherNames": [
                        "Gastric Resection"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Hyperthermic Intraperitoneal Chemotherapy",
                    "description": "Undergo HIPEC",
                    "armGroupLabels": [
                        "Treatment (gastrectomy, HIPEC)"
                    ],
                    "otherNames": [
                        "HIPEC"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Magnetic Resonance Imaging",
                    "description": "Undergo MRI",
                    "armGroupLabels": [
                        "Treatment (gastrectomy, HIPEC)"
                    ],
                    "otherNames": [
                        "Magnetic Resonance",
                        "Magnetic Resonance Imaging Scan",
                        "Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance",
                        "MR",
                        "MR Imaging",
                        "MRI",
                        "MRI Scan",
                        "NMR Imaging",
                        "NMRI",
                        "Nuclear Magnetic Resonance Imaging"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Positron Emission Tomography",
                    "description": "Undergo PE/CT",
                    "armGroupLabels": [
                        "Treatment (gastrectomy, HIPEC)"
                    ],
                    "otherNames": [
                        "Medical Imaging, Positron Emission Tomography",
                        "PET",
                        "PET Scan",
                        "Positron Emission Tomography Scan",
                        "Positron-Emission Tomography",
                        "proton magnetic resonance spectroscopic imaging",
                        "PT"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Questionnaire Administration",
                    "description": "Complete questionnaire",
                    "armGroupLabels": [
                        "Treatment (gastrectomy, HIPEC)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Hospital length of stay",
                    "description": "Descriptive statistics such as mean, standard deviation, median and range summarized.",
                    "timeFrame": "Up to 1 year"
                },
                {
                    "measure": "30 day readmission rate",
                    "description": "Descriptive statistics such as mean, standard deviation, median and range summarized.",
                    "timeFrame": "Up to 30 days post surgery"
                },
                {
                    "measure": "30 day Clavien-Dindo grade III complications",
                    "description": "Descriptive statistics such as mean, standard deviation, median and range summarized.",
                    "timeFrame": "Up to 30 days post surgery"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Disease-free survival",
                    "description": "Descriptive statistics such as mean, standard deviation, median and range summarized. Time estimated using the Kaplan-Meier method. Two-sided log-rank test used to assess differences of time to events between groups.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Peritoneal recurrence free survival",
                    "description": "Descriptive statistics such as mean, standard deviation, median and range summarized. Time estimated using the Kaplan-Meier method. Two-sided log-rank test used to assess differences of time to events between groups.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Overall survival",
                    "description": "Descriptive statistics such as mean, standard deviation, median and range summarized. Time estimated using the Kaplan-Meier method. Two-sided log-rank test used to assess differences of time to events between groups.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Open conversion rate",
                    "description": "Descriptive statistics such as mean, standard deviation, median and range summarized.",
                    "timeFrame": "Up to 42 months"
                },
                {
                    "measure": "Opioid consumption in morphine milligram equivalents",
                    "description": "Descriptive statistics such as mean, standard deviation, median and range summarized.",
                    "timeFrame": "Up to 42 months"
                },
                {
                    "measure": "Nursing reported pain scores",
                    "description": "Descriptive statistics such as mean, standard deviation, median and range summarized.",
                    "timeFrame": "Up to 42 months"
                },
                {
                    "measure": "Estimated blood loss",
                    "description": "Descriptive statistics such as mean, standard deviation, median and range summarized.",
                    "timeFrame": "Up to 42 months"
                },
                {
                    "measure": "Operative time",
                    "description": "Descriptive statistics such as mean, standard deviation, median and range summarized.",
                    "timeFrame": "Intraoperative"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Restricted to 18 to 80 years of age\n* Eastern Cooperative Oncology Group (ECOG) performance status =\\< 2\n* Histologic confirmation of gastric adenocarcinoma including all subtypes and Siewert type II/III gastroesophageal (GE) junction adenocarcinomas\n* Absolute neutrophil count \\>= 1,500 / uL\n* Platelets \\>= 50,000 / Ul\n* Serum creatinine \\<= 1.5 mg / dL\n* Adequate nutritional status (Albumin \\>= 3.5)\n* Metastasis confined to the peritoneum:\n\n  * Positive peritoneal cytology\n  * Peritoneal metastasis on diagnostic laparoscopy\n  * Peritoneal metastasis on imaging\n* Response to systemic chemotherapy defined as at least one of the following:\n\n  * Reduction ( \\>= 30%) in standardized uptake value (SUV) max (Response Evaluation Criteria in Solid Tumors \\[RECIST\\] criteria)\n  * Reduction in size of primary tumor, regional lymph node or peritoneal metastasis on imaging ( \\>= 20% decrease in the longest diameter of target lesion) RECIST criteria\n  * Reduction ( \\>= 30%) in Peritoneal Carcinomatosis Index \\[PCI\\] or conversion of peritoneal cytology\n  * Reduction ( \\>= 30%) in serum tumor markers CEA or CA 19-9\n* Peritoneal Carcinomatosis Index (PCI) =\\< 7 and surgeon deems high likelihood for a complete cytoreduction\n* Body Mass Index (BMI) =\\< 35 kg/m\\^2\n* Must enroll in Institutional Review Board (IRB) 14-009873 (NCT02530983)\n\nExclusion Criteria:\n\n* Distant metastatic disease not limited to peritoneum, such as solid organ metastases (liver, lung, bone, distant lymph node, etc)\n* Malignant ascites at time of study enrollment\n* Comorbidities that would preclude protocol therapy\n* Subjects deemed unable to comply with study and/or follow-up procedures\n* Subjects with a known hypersensitivity to protocol systemic chemotherapy that was life-threatening, required hospitalization or prolongation of existing hospitalization, or resulted in persistent or significant disability or incapacity",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "80 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "overallOfficials": [
                {
                    "name": "Travis E Grotz",
                    "affiliation": "Mayo Clinic in Rochester",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic in Rochester",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Trials Referral Office",
                            "role": "CONTACT",
                            "phone": "855-776-0015",
                            "email": "mayocliniccancerstudies@mayo.edu"
                        },
                        {
                            "name": "Travis E. Grotz, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Mayo Clinic Clinical Trials",
                    "url": "https://www.mayo.edu/research/clinical-trials"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "asFound": "Adenocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16064",
                    "name": "Stomach Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2454",
                    "name": "Hyperthermia",
                    "relevance": "LOW"
                },
                {
                    "id": "M8464",
                    "name": "Fever",
                    "relevance": "LOW"
                },
                {
                    "id": "M12307",
                    "name": "Neoplasm Metastasis",
                    "relevance": "LOW"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "T5486",
                    "name": "Stomach Cancer",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC26",
                    "name": "Wounds and Injuries"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002945",
                    "term": "Cisplatin"
                },
                {
                    "id": "D000077143",
                    "term": "Docetaxel"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000050257",
                    "term": "Tubulin Modulators"
                },
                {
                    "id": "D000050256",
                    "term": "Antimitotic Agents"
                },
                {
                    "id": "D000050258",
                    "term": "Mitosis Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M1668",
                    "name": "Docetaxel",
                    "asFound": "Blood pressure",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6182",
                    "name": "Cisplatin",
                    "asFound": "Parkinson's Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26197",
                    "name": "Tubulin Modulators",
                    "relevance": "LOW"
                },
                {
                    "id": "M26196",
                    "name": "Antimitotic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}